PRESS RELEASES
Wednesday, September 25, 2020
Genelux Announces Closing of a Strategic Financing Transaction…more
Wednesday, September 16, 2020
Genelux to Present Data from Phase 2 Trial of Olvi-Vec in Heavily Pre-treated Platinum-Resistant/Refractory Ovarian Cancer at ESMO Virtual Congress 2020…more
Thursday, September 10, 2020
Genelux Announces Oral Plenary Presentation of VIRO-15 Phase 2 Trial Data at the 2020 xDigital Annual Global Meeting of the International Gynecologic Cancer Society…more
Thursday, June 04, 2020
Genelux Announces Formation of Clinical Advisory Board on Gynecologic Cancers… more
